Cannasouth Ltd
NZX:CBD

Watchlist Manager
Cannasouth Ltd Logo
Cannasouth Ltd
NZX:CBD
Watchlist
Price: 0.098 NZD Market Closed
Market Cap: 32.4m NZD
Have any thoughts about
Cannasouth Ltd?
Write Note

Cannasouth Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cannasouth Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Cannasouth Ltd
NZX:CBD
Cost of Revenue
-NZ$2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Cost of Revenue
-NZ$110m
CAGR 3-Years
-19%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Cost of Revenue
-NZ$204.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Cost of Revenue
-NZ$97.6k
CAGR 3-Years
-99%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

Cannasouth Ltd
Glance View

Market Cap
32.4m NZD
Industry
Pharmaceuticals

Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. The firm focuses on the commercial development of the medically beneficial attributes of cannabinoid compounds such as Cannabidiol (CBD), Tetrahydrocannabinol (THC) and associated chemical structures that are produced by the cannabis plant.

CBD Intrinsic Value
0.011 NZD
Overvaluation 88%
Intrinsic Value
Price

See Also

What is Cannasouth Ltd's Cost of Revenue?
Cost of Revenue
-2.2m NZD

Based on the financial report for Dec 31, 2023, Cannasouth Ltd's Cost of Revenue amounts to -2.2m NZD.

What is Cannasouth Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
33%

Over the last year, the Cost of Revenue growth was 33%.

Back to Top